AI assistant
Sending…
SynAct Pharma — Major Shareholding Notification 2024
May 8, 2024
3114_iss_2024-05-08_33c44592-432a-40a2-88b3-c8f9dfbf66a8.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer SynAct Pharma AB
Holder
NBCD A/S
Instrument
| Instrument | Share SE0008241491 | ||
|---|---|---|---|
| Before the transaction | |||
| Shares | 0 | ||
| Voting rights | 0 | ||
| Transaction | |||
| Reason for major shareholding notification New share issue | |||
| Date | 08/05/2024 | ||
| Limit for number of shares | 5 % | ||
| Limit for number of votes | 5 % | ||
| After the transaction | |||
| Quantity | |||
| Shares | 3,962,790 | ||
| Directly held voting rights | 3,962,790 | ||
| Indirectly held voting rights | 0 | ||
| Percentage | |||
| Directly held shares | 9.59595 % | ||
| Directly held voting rights | 9.59595 % | ||
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 9.59595 % | 3,962,790 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 9.59595 % | 3,962,790 |
| Published | ||
| 08/05/2024 12:47 Contact |
||
| Name Filip Landenius |
||
| Phone 0735798786 Email [email protected] |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from SynAct Pharma
Regulatory Filings
2026
May 8
AGM Information
2026
May 7
Board/Management Information
2026
Apr 23
Governance Information
2026
Apr 23
Annual Report
2026
Apr 15
Major Shareholding Notification
2026
Apr 7
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 2